Nanjing BioPredia Medicine Co., Ltd (a wholly owned subsidiary) is a technology-oriented biotechnology company focusing high-throughput detection technology and product development of liquid-phase chip. The company uses the liquid-phase chip technology platform (also known as flow fluorescence technology platform) to develop and produce multi-factor immunoassay kit products. The joint detection kit is composed of the test combination which has been widely used in clinical practice. Compared with the single factor detection product, it improves detection efficiency, reduces labor and sample consumption, and also the detection cost. Products include five categories: tumor markers, sex hormones and thyroid function, autoimmune diseases, cytokines, other categories (including allergens, torch, 8 items before operation, etc.) series products. At the same time, the company also carries out technical consulting, technical services and other businesses around the flow technology and platform.
As one of the strongest teams in China, the expert team of prodiconning has a great advantages in the development technology of liquid-phase chip immune joint inspection products. With the efforts of all members, prodiconning is confident to develop into a high-tech biological company with the strongest strength in high-throughput immunoassay technology and the most complete category of joint inspection products in China.
ADD: Room 2102-2104, building B, phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1, xinjinhu Road, Nanjing high tech Development Zone
TEL: 025-58877005 18018074429
E-Mail: pdkn@biopredia.com
